← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Letrozole currently has availability issues reported in 2 European registers: Greece, Ireland.
Shortage ATC L02BG04 · also listed as: LETROZOLE · data refreshed 14 September 2026
As of 14 September 2026, 2 of the 9 tracked registers list current availability issues for Letrozole, covering 3 affected product presentations. The longest-running open report was filed in Ireland on 2026-02-03 and has now been open for about 7 months. Where agencies state a cause, delivery delays lead with 1 of the 3 stated-cause reports, followed by unexpectedly high demand with 1. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Letrozole is coded L02BG04 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability STEFAPLEX F.C.TAB 2,5MG/TAB BT x 30 (BLIST 3x10) | 2026-06-15 | 2026-09-30 | OPUS MATERIA ΕΠΕ Καθυστέρηση παράδοσης περιεκτικότητας | register ↗ |
| 🇮🇪 Ireland | Shortage Letrozole 2.5 mg film-coated tablets + 1 more productsLetrozole Teva 2.5 mg film-coated tablets | 2026-02-03 | 2026-09-11 | Unexpected increased demand Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Letrozole in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | STEFAPLEX F.C.TAB 2,5MG/TAB BT x 30 (BLIST 3x10) | Limited availability | 2026-06-15 | 2026-09-30 | OPUS MATERIA ΕΠΕ Καθυστέρηση παράδοσης περιεκτικότητας |
| 🇮🇪 IE | Letrozole Teva 2.5 mg film-coated tablets | Shortage | 2026-05-06 | 2026-09-11 | Manufacturing delay (Multiple countries) |
| 🇮🇪 IE | Letrozole 2.5 mg film-coated tablets | Shortage | 2026-02-03 | 2026-08-15 | Unexpected increased demand |
Yes. As of 14 September 2026, availability issues are reported in: Greece, Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Letrozole: EOF limited-availability list (Greece), HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Letrozole — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/letrozole/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Letrozole availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/letrozole/">Letrozole shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>